OnCusp Therapeutics Appoints Dimitry Nuyten, M.D., Ph.D., as Chief Medical Officer
PRINCETON, N.J., June 23, 2025 /PRNewswire/ -- OnCusp Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients, today...
Mobile industry emissions down 8%, but pace must double to hit net zero
LONDON, June 18, 2025 /PRNewswire/ -- The mobile industry's operational emissions fell by 8% between 2019 and 2023, even as mobile connections grew by 9% and data traffic quadrupled, according to the GSMA's fifth annual Mobile Net Zero report...
Univar Solutions Publishes 2024 Environmental, Social and Governance (ESG) Report
As the Company enters the final year of its current ESG goals highlights show significant progress on all fronts, including its Sustainable & Natural Products portfolio. DOWNERS GROVE, Ill., June 10, 2025 /PRNewswire/ -- Univar Solutions LLC...
GAR Profits Surge in Competitive Market Environment During the First Quarter of 2025
Net profit for the quarter surged by 47% year-on-year to US$55 million. Growth in plantation output helped to offset softer downstream performance, resulting in a first quarter 2025 EBITDA margin of over 8.5%. SINGAPORE, May 15, 2025 /PRNewswire/ --...
Antengene Announces 2024 Full-Year Financial Results, Proprietary Programs Advancing to Pivotal Trials with Accelerating Multi-market Revenue Ramp Up
SHANGHAI and HONG KONG, March 21, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) today announced its full-year results for the period ending December 31, 2024, along with several significant milestones achieved in...
Woolf Introduces Performance Based Admissions - A Milestone in Expanding Global Access to Higher Education
SAN FRANCISCO, Dec. 9, 2024 /PRNewswire/ -- Woolf, a global collegiate higher education institution, has announced the launch of its Performance Based Admissions (PBA) system, built on Woolf's innovative StudyTrack technology. This marks a...